Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Jul 7, 2014

30718_dirs_2014-07-07_2e465e97-4a31-46dd-9881-cb85ee1da82b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-07-02

Reporting Person: EANSOR N DAVID (SVP - Novus Biologicals)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-02 Restricted Stock Units $ A 5000 Acquired Common Stock (5000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Techne Corporation common stock.

F2: The restricted stock units vest in three equal annual installments beginning July 1, 2015. Shares will be delivered to the reporting person following vesting.